Helen Bateup

Dr. Helen Bateup


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2022 in Nature
Verified
Journal Article
Closed access
PDF file
Sergiu PascaSergiu Pasca
Sergiu Pasca
PAPaola Arlotta
Paola Arlotta
HBHelen Bateup
Helen Bateup
JCJ. Gray Camp
J. Gray Camp
SCSilvia Cappello
Silvia Cappello
FVFlora Maria Vaccarino
Flora Maria Vaccarino

20 August 2018 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
JBJohn D. Blair
John D. Blair
DHDirk Hockemeyer
Dirk Hockemeyer
HBHelen Bateup
Helen Bateup

7 July 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
LYLívia H. Yamashiro
Lívia H. Yamashiro
SWStephen C. Wilson
Stephen C. Wilson
HMHuntly M. Morrison
Huntly M. Morrison
VKVasiliki Karalis
Vasiliki Karalis
JCJing-Yi J. Chung
Jing-Yi J. Chung
RVRussell E. Vance
Russell E. Vance
The Stimulator of Interferon Genes (STING) pathway initiates potent immune responses upon recognition of DNA. To initiate signaling, serine 365 (S365) in the C-terminal tail (CTT) of STING is phosphorylated, leading to induction of type I interferons (IFNs). Additionally, evolutionary conserved responses such as autophagy also occur downstream of STING, but their relative importance during in vivo infections remains unclear. Here we report that mice harboring a serine 365-to-alanine (S365A) mutation in STING are unexpectedly resistant to Herpes Simplex Virus (HSV)-1, despite lacking STING-induced type I IFN responses. By contrast, resistance to HSV-1 is abolished in mice lacking the STING CTT, suggesting that the STING CTT initiates protective responses against HSV-1, independently of type I IFNs. Interestingly, we find that STING-induced autophagy is a CTT- and TBK1-dependent but IRF3-independent process that is conserved in the STING S365A mice. Thus, interferon-independent functions of STING mediate STING-dependent antiviral responses in vivo.

1 November 2017 in Cell Reports
Verified
Journal Article
Open access
JBJohn D. Blair
John D. Blair
DHDirk Hockemeyer
Dirk Hockemeyer
JDJennifer A. Doudna
Jennifer A. Doudna
HBHelen Bateup
Helen Bateup
SFStephen N. Floor
Stephen N. Floor
Faithful cellular differentiation requires temporally precise activation of gene expression programs, which are coordinated at the transcriptional and translational levels. Neurons express the most complex set of mRNAs of any human tissue, but translational changes during neuronal differentiation remain incompletely understood. Here, we induced forebrain neuronal differentiation of human embryonic stem cells (hESCs) and measured genome-wide RNA and translation levels with transcript-isoform resolution. We found that thousands of genes change translation status during differentiation without a corresponding change in RNA level. Specifically, we identified mTOR signaling as a key driver for elevated translation of translation-related genes in hESCs. In contrast, translational repression in active neurons is mediated by regulatory sequences in 3' UTRs. Together, our findings identify extensive translational control changes during human neuronal differentiation and a crucial role of 3' UTRs in driving cell-type-specific translation.

9 December 2024 in Nature
Verified
Journal Article
Open access
PDF file
Sergiu PascaSergiu Pasca
Sergiu Pasca
PAPaola Arlotta
Paola Arlotta
HBHelen Bateup
Helen Bateup
JCJ. Gray Camp
J. Gray Camp
SCSilvia Cappello
Silvia Cappello
TYTracy Young-Pearse
Tracy Young-Pearse
As the field of neural organoids and assembloids rapidly expands, there is an emergent need for guidance and advice on designing, conducting and reporting experiments to increase the reproducibility and utility of these models. Here, our consortium– representing specialized laboratories from around the world– presents a framework for the experimental process that ranges from ensuring the quality and integrity of human pluripotent stem cells to characterizing and manipulating neural cells in vitro, and from transplantation techniques to considerations for modeling human development, evolution, and disease. As with all scientific endeavors, we advocate for rigorous experimental designs tailored to explicit scientific questions, and transparent methodologies and data sharing, to provide useful knowledge for both current research practices and for developing regulatory standards.

23 July 2021 in Frontiers in Neural Circuits
Verified
Journal Article
Open access
PKPolina Kosillo
Polina Kosillo
HBHelen Bateup
Helen Bateup
Autism spectrum disorder (ASD) is a neurodevelopmental disorder defined by altered social interaction and communication, and repetitive, restricted, inflexible behaviors. Approximately 1.5-2% of the general population meet the diagnostic criteria for ASD and several brain regions including the cortex, amygdala, cerebellum and basal ganglia have been implicated in ASD pathophysiology. The midbrain dopamine system is an important modulator of cellular and synaptic function in multiple ASD-implicated brain regions via anatomically and functionally distinct dopaminergic projections. The dopamine hypothesis of ASD postulates that dysregulation of dopaminergic projection pathways could contribute to the behavioral manifestations of ASD, including altered reward value of social stimuli, changes in sensorimotor processing, and motor stereotypies. In this review, we examine the support for the idea that cell-autonomous changes in dopaminergic function are a core component of ASD pathophysiology. We discuss the human literature supporting the involvement of altered dopamine signaling in ASD including genetic, brain imaging and pharmacologic studies. We then focus on genetic mouse models of syndromic neurodevelopmental disorders in which single gene mutations lead to increased risk for ASD. We highlight studies that have directly examined dopamine neuron number, morphology, physiology, or output in these models. Overall, we find considerable support for the idea that the dopamine system may be dysregulated in syndromic ASDs; however, there does not appear to be a consistent signature and some models show increased dopaminergic function, while others have deficient dopamine signaling. We conclude that dopamine dysregulation is common in syndromic forms of ASD but that the specific changes may be unique to each genetic disorder and may not account for the full spectrum of ASD-related manifestations.